- Home
- TAK vs EXC Comparison
TAK vs EXC Comparison
Compare TAK & EXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- EXC
- Stock Information
- Founded
- TAK 1781
- EXC 1999
- Country
- TAK Japan
- EXC United States
- Employees
- TAK N/A
- EXC N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- EXC Power Generation
- Sector
- TAK Health Care
- EXC Utilities
- Exchange
- TAK Nasdaq
- EXC Nasdaq
- Market Cap
- TAK 42.2B
- EXC 46.5B
- IPO Year
- TAK N/A
- EXC N/A
- Fundamental
- Price
- TAK $14.71
- EXC $47.26
- Analyst Decision
- TAK
- EXC Buy
- Analyst Count
- TAK 0
- EXC 8
- Target Price
- TAK N/A
- EXC $45.63
- AVG Volume (30 Days)
- TAK 2.5M
- EXC 11.3M
- Earning Date
- TAK 05-08-2025
- EXC 05-01-2025
- Dividend Yield
- TAK 4.01%
- EXC 3.39%
- EPS Growth
- TAK 15.39
- EXC 4.82
- EPS
- TAK 0.83
- EXC 2.45
- Revenue
- TAK $29,124,927,177.00
- EXC $23,028,000,000.00
- Revenue This Year
- TAK $8.53
- EXC $4.58
- Revenue Next Year
- TAK N/A
- EXC $2.98
- P/E Ratio
- TAK $34.69
- EXC $19.29
- Revenue Growth
- TAK 9.83
- EXC 5.99
- 52 Week Low
- TAK $12.58
- EXC $34.01
- 52 Week High
- TAK $15.37
- EXC $48.11
- Technical
- Relative Strength Index (RSI)
- TAK 52.69
- EXC 64.49
- Support Level
- TAK $13.60
- EXC $46.33
- Resistance Level
- TAK $15.37
- EXC $48.11
- Average True Range (ATR)
- TAK 0.33
- EXC 1.33
- MACD
- TAK -0.03
- EXC 0.12
- Stochastic Oscillator
- TAK 62.71
- EXC 83.84
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About EXC Exelon Corporation
Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.